Chronic Pyelonephritis
- Author: James W Lohr, MD; Chief Editor: Vecihi Batuman, MD, FACP, FASN more...
Background
Chronic pyelonephritis is characterized by renal inflammation and fibrosis induced by recurrent or persistent renal infection, vesicoureteral reflux, or other causes of urinary tract obstruction. The diagnosis of chronic pyelonephritis is made based on imaging studies such as ultrasound or CT scanning. It occurs almost exclusively in patients with major anatomic anomalies, most commonly in young children with vesicoureteral reflux (VUR).[1]
VUR is a congenital condition that results from incompetence of the ureterovesical valve due to a short intramural segment. VUR is present in 30-40% of young children with symptomatic UTIs and in almost all children with renal scars. It may also be acquired by patients with a flaccid bladder due to spinal cord injury. VUR is classified into 5 grades (I-V), according to the increasing degree of reflux. (See Treatment.) The diagnosis of VUR is frequently established based on radiologic evidence obtained during an evaluation for recurrent urinary tract infection (UTI) in young children.
Differential considerations
Analgesic abuse nephropathy, renal tuberculosis, renal dysplasia, xanthogranulomatous pyelonephritis, and renal malakoplakia may resemble chronic pyelonephritis. In malakoplakia, however, characteristic inclusions called Michaelis-Gutmann bodies are seen on biopsy.
Patient education
For patient education information, see Urinary Tract Infections (UTIs).
Etiology and Pathophysiology
Chronic pyelonephritis is associated with progressive renal scarring, which can lead to end-stage renal disease (ESRD). For example, in reflux nephropathy, intrarenal reflux of infected urine is suggested to induce renal injury, which heals with scar formation.[2] In some cases, scars may form in utero in patients with renal dysplasia with perfusion defects. Infection without reflux is less likely to produce injury. Dysplasia may also be acquired from obstruction. Scars of high-pressure reflux can occur in persons of any age. In some cases, normal growth may lead to spontaneous cessation of reflux by age 6 years.
Factors that may affect the pathogenesis of chronic pyelonephritis are as follows: (1) the sex of the patient and his or her sexual activity; (2) pregnancy, which may lead to progression of renal injury with loss of renal function; (3) genetic factors; (4) bacterial virulence factors; and (5) neurogenic bladder dysfunction. In cases with obstruction, the kidney may become filled with abscess cavities (see Pyonephrosis).
Epidemiology
In the United States, VUR may be present in 30-40% of children with UTIs. The prevalence rate of VUR in siblings of patients with chronic pyelonephritis is approximately 35%. VUR and chronic pyelonephritis are less common in African American children than in white children, with chronic pyelonephritis occurring 3 times more often in white children.[3] Chronic pyelonephritis is also twice as common in females as it is in males.
Chronic pyelonephritis occurs more often in infants and young children (younger than 2 y) than it does in older children and adults.
Prognosis
The Birmingham Reflux Study clearly showed that medical and surgical management are equally effective in preventing renal damage from VUR.[4] Almost all children should receive a trial of medical management.
Although most children with chronic pyelonephritis due to VUR may experience spontaneous resolution of reflux, approximately 2% can still progress to renal failure, and 5-6% can have long-term complications, including hypertension.[5]
Hypertension contributes to the accelerated loss of renal function in persons with chronic pyelonephritis. Reflux nephropathy is the most common cause of hypertension in children, occurring in 10-20% of children with VUR and renal scars. The resolution of reflux does not appear to correct hypertension.
Complications of chronic pyelonephritis can also include the following:
- Proteinuria
- Focal glomerulosclerosis
- Progressive renal scarring leading to end-stage renal disease[6]
- Xanthogranulomatous pyelonephritis (XPN) - May occur in approximately 8.2% of cases and in 25% of patients with pyonephrosis; XPN can be confused with renal cancer[7, 8, 9, 10, 11]
- Pyonephrosis - May occur in cases of obstruction
- Progressive renal scarring (reflux nephropathy)
Guarino N, Casamassima MG, Tadini B, et al. Natural history of vesicoureteral reflux associated with kidney anomalies. Urology. Jun 2005;65(6):1208-11. [Medline].
Dillon MJ, Goonasekera CD. Reflux nephropathy. J Am Soc Nephrol. Dec 1998;9(12):2377-83. [Medline].
Chand DH; Rhoades T; Poe SA; Kraus S; Strife CF. Incidence and severity of vesicoureteral reflux in children related to age, gender, race and diagnosis. J Urol 2003 Oct [serial online]. 170(4 Pt 2):1548-50. Available at [Medline].
Birmingham Reflux Study Group. Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham Reflux Study Group. Br Med J (Clin Res Ed). Jul 25 1987;295(6592):237-41. [Medline].
Köhler J, Tencer J, Thysell H, et al. Vesicoureteral reflux diagnosed in adulthood. Incidence of urinary tract infections, hypertension, proteinuria, back pain and renal calculi. Nephrol Dial Transplant. Dec 1997;12(12):2580-7. [Medline].
Zermann DH, Loffler U, Reichelt O, et al. Bladder dysfunction and end stage renal disease. Int Urol Nephrol. 2003;35(1):93-7. [Medline].
Alan C, Ataus S, Tunc B. Xanthogranulamatous pyelonephritis with psoas abscess: 2 cases and review of the literature. Int Urol Nephrol. 2004;36(4):489-93. [Medline].
Gonzalez Resina R, Barrero Candau R, Arguelles Salido E, et al. [Xanthogranulomatous pyelonephritis in childhood. A case report]. Actas Urol Esp. Jun 2005;29(6):596-8. [Medline].
Oosterhof GO, Delaere KP. Xanthogranulomatous pyelonephritis. A review with 2 case reports. Urol Int. 1986;41(3):180-6. [Medline].
Saavedra Jo S, Pow-Sang Godoy M, Benavente Corrales V, et al. [Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics]. Arch Esp Urol. Jul-Aug 2004;57(6):595-600. [Medline].
Zugor V, Amann K, Schrott KM, et al. [Xanthogranulomatous pyelonephritis: presentation of an unusual case]. Aktuelle Urol. Jun 2005;36(3):245-8. [Medline].
Hiraoka M, Hori C, Tsukahara H, et al. Vesicoureteral reflux in male and female neonates as detected by voiding ultrasonography. Kidney Int. Apr 1999;55(4):1486-90. [Medline].
Dracon M, Lemaitre L. [Urinary tract infection in adult. Leukocyturia]. Rev Prat. May 15 2003;53(10):1137-42. [Medline].
Noe HN. The long-term results of prospective sibling reflux screening. J Urol. Nov 1992;148(5 Pt 2):1739-42. [Medline].

